Lifeboat Foundation

Life is usefully defined on the basis of process: Any set of entities that participates in the process of evolution by natural selection is alive. But how does evolution by natural selection—and thus life—get started? The answer is far from obvious. Lack of insight haunts origins of life research and plagues understanding of the major evolutionary transitions, including the transition from cells to multicellular life.

In a new paper published in Nature Ecology & Evolution, a team led by Paul Rainey at ESPCI Paris and the Max Planck Institute for Evolutionary Biology provides a solution. Adopting a theoretical approach inspired from earlier and on-going experiments, Rainey and his team show how ecological circumstances can kick-start life, both from the get-go, and also at each of the major evolutionary transitions.

For entities to participate in the process of evolution by natural selection, entities need to be discreet and vary one to another, entities must replicate and offspring must resemble parental types. These basic Darwinian properties (variation, reproduction and heredity) are such fundamental features of life that it is easy to take their existence for granted. But as Black et al point out, Darwinian properties are derived and require evolutionary explanation. In the absence of any manifestation of heritable variance in fitness evolution is governed by chance alone and the road out of randomness difficult to conceive.

HONG KONG, Feb. 11, 2020 /PRNewswire/ — Infectious diseases represent an important portion of global public health concerns¸ in particular with regard to the current global outbreak of novel coronavirus (2019-nCoV). The challenge of frontline diagnosis in hospitals, clinics and ports is that infectious diseases could exhibit similar symptoms or can be asymptomatic. The Hong Kong Polytechnic University (PolyU) today announced the development of the world’s most comprehensive automated multiplex diagnostic system (the System) which includes a fully automated machine and a multiplex full-screening panel for the point-of-care genetic testing (POCT) of respiratory infectious disease including the 2019-nCoV.

Of interest here?

The coauthors of the seminal book The Virtual Corporation describe how the rise of artificial intelligence and virtual environments are ushering in an epic cultural transformation—and how we can thrive in this new era.

https://www.youtube.com/watch?v=HVejUrKnh6E&feature=youtu.be

SUPPORT THIS PROJECT, BUY THE DVD (only $8.99 with coupon code: “burz51”): http://estore.burzynskimovie.com
For more info: http://www.oprah.com/oprahradio/Dr-Stanislaw-Burzynskis-Cure-for-Cancer-Audio
Burzynski the Movie: http://www.burzynskimovie.com/

Follow this film series on Facebook: https://www.facebook.com/BurzynskiMovie

Continue reading “Dr. Mehmet Oz interviews Dr. Burzynski & Eric Merola” »

The applications are almost endless.

In “Hacking the Code of Life”, Nessa Carey explores advances that are giving us new powers to alter the genome.

It becomes obvious, that there are clump risks in the current setup of the global drug production.

There may soon be a shortage of certain drugs, such as some antibiotics (•, as the only production facilities in China stopped producing them, due to the current Corona virus outbreak.

(• e.g. consider that 97% of the antibiotics used in America are made in China according to an article by ABC7 news.

Continue reading “The Coronavirus Is a Threat to the Global Drug Supply” »

Artificial intelligence is being used in an unexpected way; helping perfume makers create their next great fragrance. Veuer’s Justin Kircher has the story.

Lifespan.io is hosting its third annual conference on aging and rejuvenation biotechnology.

The Life Extension Advocacy Foundation/Lifespan.io, a nonprofit company promoting aging research, is hosting its third annual Ending Age-Related Diseases: Investment Prospects and Advances in Research conference on August 20–21 at the Stern Auditorium of the Icahn School of Medicine at Mount Sinai (New York City, USA).

The goal of this conference is to promote scientific and public discussion in order to foster the development of interventions that target aging and are capable of relieving our aging society from the burden of age-related diseases. Key topics of the conference include biomarkers of aging, discoveries in fundamental research, the development of interventions targeting the root mechanisms of aging, investment strategies, and regulatory issues that are relevant to rejuvenation research.

Read more